Z226173

Nucleosil^® C18 HPLC Column

5 μm particle size, L × I.D. 15 cm × 4.6 mm

• Synonim(y): Nucleosil C18
• Kod UNSPSC: 41115700
• eCl@ss: 32110501
• NACRES: SB.52

Właściwości

• agency: suitable for USP L1
• Poziom jakości: 100
• linia produktu: Nucleosil^®
• Właściwości: endcapped
• producent / nazwa handlowa: Nucleosil^®
• zakres etykietowania: 15% Carbon loading
• Parametry: ≤70 °C temp. range; 400 bar pressure (5801 psi)
• metody: HPLC: suitable
• dł. × śr. wewn.: 15 cm × 4.6 mm
• powierzchnia: 350 m²/g
• Matryca: octadecyl
• grupa aktywna macierzy: C18 (octadecyl) phase
• wielkość cząstki: 5 μm
• wielkość porów: 100 Å
• metoda separacji: reversed phase

Opis

Zastosowanie

• Quantification and Validation of Stability-Indicating RP-HPLC Method for Efavirenz: Demonstrates the utility of Nucleosil^® C18 HPLC Column in pharmaceutical analysis, particularly in quality control and stability testing of Efavirenz, ensuring compliance with regulatory standards (Gurumukhi VC, Bari SB, 2022).


• Development of new method for simultaneous analysis of piracetam and levetiracetam: This study uses the Nucleosil^® C18 column to develop robust methods for analyzing neurological medications in pharmaceuticals and biological fluids, contributing to drug stability studies (Siddiqui FA et al., 2014).


• HPLC method for determination of biologically active epoxy-transformers of treosulfan: The column′s application in plasma analysis highlights its role in pharmacokinetic studies, offering precise measurements critical for dosing and therapeutic monitoring (Główka FK et al., 2012).


• HPLC analysis of mitoxantrone in mouse plasma and tissues: Illustrates the column′s effectiveness in a pharmacokinetic study, underscoring its importance in the preclinical evaluation of cancer therapies (An G, Morris ME, 2010).


• Development and validation of an HPLC method for vancomycin: This application in a pharmacokinetic study highlights the column′s critical role in the development and validation of methods for antibiotic analysis, ensuring therapeutic efficacy and safety (Jesús Valle MJ et al., 2008).

Polecane produkty

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

Informacje prawne

Nucleosil is a registered trademark of Macherey-Nagel GmbH & Co. KG

Ta strona może zawierać tekst przetłumaczony maszynowo.